We also assessed 7 cancer cell lines with different CUL4A and B expressions and observed an inverse correlation between CUL4 protein levels and SN38 sensitivity (Supplementary Data Fig. 4g, h), indicating CUL4 proteins as potential predictive biomarkers for TOP1 inhibitors. The gene discussed is CUL4A; the disease is cancer.